Navigation Links
Baxter Reports Solid First Quarter Financial Results and Raises Full-Year Outlook
Date:4/17/2008

Three Months Ended March 31,

----------------------------

2008 2007

---------- -----------

Net income $429 $403

Adjustments

Depreciation and amortization 156 140

Deferred income taxes 61 (13)

Stock compensation 38 27

Infusion pump charge 53 -

Other 9 4

Changes in balance sheet items

Receivables 18 (98)

Inventories (105) (128)

Accounts payable and accrued liabilities (341) (158)

Restructuring payments (12) (3)

Other 56 41

-------------------------------------------------------------------------

Cash flows from operations $362 $215

=========================================================================

Changes in Net Debt

Increase (decrease)

Three Months Ended March 31,

----------------------------

2008 2007

---------- -----------

Net debt, beginning of period $550 $316

Cash flows from operations (362)
'/>"/>

SOURCE Baxter International Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19

Related biology technology :

1. Baxter to Launch GARDian(TM), a Groundbreaking Initiative That Helps Provide Continued Access to GAMMAGARD for Current Patients
2. Baxter and Halozyme Announce Collaboration for Development of Subcutaneous GAMMAGARD LIQUID(TM) Administration Using Enhanze(TM) Technology
3. Baxter Named to Dow Jones Sustainability Index for Ninth Consecutive Year
4. Baxter and Novation Sign Multi-Year Contract Extension Valued at Over $200 Million for Medication Delivery Products
5. Baxter Adds Recombinant Protein to Specialty Therapeutics Portfolio
6. Baxter Kidney Patient Education Program Celebrates Tenth Anniversary
7. Baxter Receives 510(k) Clearance From FDA For V-Link With VitalShield, New Antimicrobial Intravascular Technology
8. Baxter Announces FDA Approval of GELFOAM(R) Plus Hemostasis Kit
9. Baxter International Fourth Quarter 2007 Financial Results Conference Call
10. Baxter Issues Urgent Nationwide Voluntary Recall of Heparin 1,000 Units/mL 10 and 30mL Multi-Dose Vials
11. Baxters Costa Rica Facility Recognized With Shingo Prize for Excellence in Manufacturing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... 15 Reportlinker.com announces that a ... its catalogue: ,, The Future ... to 2015, Pipeline Analysis and Reimbursement ... ,, Summary ,, The ... Future of Orphan Diseases Therapeutics - Market ...
(Date:12/15/2009)... diameter NeedleProbes™ for Atomic Force Microscopy (AFM) have been ... for studies at the liquid/air interface. The NeedleProbes’ cylindrical ... height, evaporation rate and viscosity - all in a single ... ... December 15, 2009 -- New, constant diameter NeedleProbes ...
(Date:12/15/2009)... Dec. 15 The Center for ... Communications, is pleased to announce the full ... Accounting and Reporting Congress . The forum ... on March 16-17, 2010. ,, Over 1,500 ... have attended this premier event since its ...
(Date:12/15/2009)... Belgium, December 15 , ... Designed to Evaluate the Ability of,Cardiopoietic Cells to ... Cardio3 BioSciences, a leading Belgian biotechnology company specialising,in ... today that it has completed, two months ahead ... pivotal Phase II/III trial of C-Cure, a,unique stem ...
Breaking Biology Technology:Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 2Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 3Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 4Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 5Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 6Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 7Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 8Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 9Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 10Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 11Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 12Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 13Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 14Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 15Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 16Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 17Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 18New Constant Diameter NeedleProbes™ with Unique Ability to Measure Liquid Surface Properties by AFM 2New Constant Diameter NeedleProbes™ with Unique Ability to Measure Liquid Surface Properties by AFM 3CBI Announces the Agenda for Their 6th Annual Pharmaceutical/Biotech Accounting and Reporting Congress 2Cardio3 BioSciences Completes Patient Enrolment in First Stage of Pivotal Trial of C-Cure(R) in Heart Failure 2Cardio3 BioSciences Completes Patient Enrolment in First Stage of Pivotal Trial of C-Cure(R) in Heart Failure 3
... Aug. 26 The 2008 European Gene,Expression ... to,Israel-based Vascular Biogenics Ltd. for developing the ... facilitated novel advancements,in gene expression-based treatments where ... platform is a potent and flexible technology ...
... Will Discuss Recent FDA Advisory Regarding BYETTA, SAN ... ) and Eli Lilly and Company (NYSE: LLY ... 26 at 5:00 p.m. ET/2:00 p.m. PT to,discuss the ... for Amylin will be Daniel M. Bradbury, Amylin,s President ...
... and MUMBAI, India, Aug. 25 ,Codexis, Inc., ... Pharmalabs,Limited, a leading Indian active pharmaceutical ingredients ... new strategic,collaboration, expanding their three-year partnership in ... CA, will offer multiple pharmaceutical,intermediates and active ...
Other Biology Technology:Vascular Biogenics Ltd. Presented With the Frost & Sullivan 2008 European Gene Expression Targeting Platform Technology Innovation Award 2Vascular Biogenics Ltd. Presented With the Frost & Sullivan 2008 European Gene Expression Targeting Platform Technology Innovation Award 3Amylin and Lilly Set Date and Time for Conference Call 2Codexis, Arch Announce Expanded Collaboration 2Codexis, Arch Announce Expanded Collaboration 3
(Date:12/15/2009)... Economics, environmental impacts, social dynamics, and production levels ... success of an agroecosystem. Positive or negative, these ... and social groups to continuously adapt farming and ... Experiential learning theory suggests that knowledge is gained ... lessons are especially valuable for environmental and agricultural ...
(Date:12/15/2009)... American researchers found the fossil remains of a whale, 4.5 ... for the first time, the results of the decay and ... cetacean, possibly a baleen whale from the Mysticeti group. , ... remains of a whale from the Lower Pliocene (five million ... is the first time that the results of the processes ...
(Date:12/15/2009)... PTR Group, a leading real-time and embedded technology engineering ... sponsor three high school teams for the 2010 season ... ). ,, The PTR Group will provide funding ... The teams from Atholton HS in Columbia, MD, ... in Vienna, VA all have direct mentorship from engineers ...
Breaking Biology News(10 mins):Experiential learning teaches change and adaptation 2Story of 4.5 million-year-old whale unveiled in Huelva 2Story of 4.5 million-year-old whale unveiled in Huelva 3The PTR Group Announces Financial and Technical Support to US FIRST Robotics Competition Teams 2Caffeine doesnt reverse the negative cognitive impact of alcohol study shows 62756 1Caffeine doesnt reverse the negative cognitive impact of alcohol study shows 62756 2Caffeine doesnt reverse the negative cognitive impact of alcohol study shows 62756 3AACR names Perou 2009 Outstanding Investigator for Breast Cancer Research 11016 1AACR names Perou 2009 Outstanding Investigator for Breast Cancer Research 11016 2Genome BC collaborates with Chile and Norway to sequence salmon genome 11011 1Genome BC collaborates with Chile and Norway to sequence salmon genome 11011 2
... movement in patients with Huntington's disease on average by ... improvement, according to a study in the February 14 ... who received the medication were six times as likely ... considerably, compared to participants who received a placebo. , ...
... multi-decade debate about how the brain knows where limbs are without ... and feet when you walk. Your brain knows where they are. ... achieves this: , (1) the outflow hypothesis says that the brain ... to contract, and uses this to predict where the limb has ...
... they have finished the first complete analysis of ... important model organisms: S. cerevisiae (baker's yeast). The ... with the European Molecular Biology Laboratory (EMBL), appears ... "To carry out their tasks, most proteins work ...
Other Biology News:Study finds drug may cut down involuntary movements 2Study finds drug may cut down involuntary movements 3How does the brain know what the right hand is doing? 2The closest look ever at the cell's machines 2The closest look ever at the cell's machines 3
... mass detection but not structural information ... spectrometer is ideally suited for high ... performance mass analysis. Typical applications ... detection, micro-satellite DNA characterization and polymer ...
Rat Lung Fibroblasts (RLF) (>500,000 cells)...
... is an ideal small concentrator for the ... of removing water and organic solvents from ... microplates, vials and round bottom flasks. Making ... busy lab. ,The built-in special runs for ...
... suitable for use with a wide range ... to water and some of the higher ... of removing water and organic solvents from ... microplates, vials and round bottom flasks; making ...
Biology Products: